CJC 1295(without DAC)5mg+IPA5mg

CJC-1295 without DAC + Ipamorelin research reference

This research blend combines a GHRH-pathway analogue with ipamorelin, a ghrelin-receptor agonist studied in experimental growth-hormone signaling models. The two components act through distinct signaling pathways and should be evaluated separately as well as in combination.

Research areas

• GHRH and ghrelin-receptor signaling.
• Growth-hormone secretory pathways.
• Experimental combination research.

Evidence context

Evidence for the combination is limited and should not be extrapolated into established clinical outcomes.

For research purposes only. Not intended for human consumption, self-administration or use as a medicine.